37 results
P
Fabry disease patients, symptomatic female carriers
I/C
X chromosome inactivation analysis, correlation between XCI and symptoms/phenotype
O
manifesting Fabry carriers, Mainz Severity Score Index, cardiac involvement
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6 mm), longer implants (≥ 8 mm)
O
bone augmentation
P
WHO Unity Studies Household Transmission Investigations
I/C
First Few X cases, HHTIs, crude data
O
hSAR, 95% confidence intervals
P
diabetic foot ulcer patients
I/C
MRI, PET, SPECT, scintigraphy, X-rays, other imaging tests
O
diagnostic accuracy of osteomyelitis
P
Osteoporotic vertebral compression fractures (OVCFs)
I/C
Percutaneous vertebral augmentation (PVA), Bilateral straight PVA, Unilateral curved PVA
O
Operative time, injected bone cement volume, bone cement leakage rate, X-ray frequency
P
human body, disease, pathology
I/C
X-ray scans, biopsy, CT-scan, accurate and reliable early disease predictions
O
effective treatment, avoiding complications
P
subjects with cigarette smoking history
I/C
computed tomography lung screening (CTLS), no screening (NS) or chest x-ray (CXR)
O
lung cancer-related mortality, early-stage tumors diagnosis, late-stage tumors diagnosis, resectability rate, all-cause mortality, overdiagnosis rate
P
asymptomatic postmenopausal women
I/C
Vertebral Fracture Assessment (VFA) by dual-energy X-ray absorptiometry, controls
O
prevalence of VFA-detected vertebral fractures
P
patients who meet WHO dual X-ray absorptiometry (DXA) osteoporosis criteria
I/C
computed tomography (CT) images, DXA scans
O
diagnosis of osteoporosis
P
adult individuals (20-59 years)
I/C
serum concentrations of 25-hydroxyvitamin D, random effect model
O
bone health evaluated through dual X-ray absorptiometry and serum concentrations of 25(OH)D